Companies similar to PDT
Sign up to Download

31-60 of 6,765,925 results

  • www.ys-ac.com
  • 1
  • 1
  • 4
Establishment of company was settled on 8th of October,2010 as an independent company from Y'sTherapeutics Co., Ltd., with an aim to develop the cancer therapy by a humanized monoclonal antibody against CD26 molecule(YS110) which is expressing on a..
Relevance: 18.33146
  • www.medigear.co.jp
  • 1
  • 1
MediGear International Corporation is a certified startup from Tokyo Institute of Technology. With the concept of "Beyond the Pill", we offer "drug-free tumor-targeted minimally invasive therapy" that improves the QOL of cancer patients who have no..
Relevance: 18.243195
  • www.akamisbio.com
  • 1
  • 2
Akamis Bio is a clinical-stage oncology company whose mission is to leverage its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer. To achieve that mission, the company is..
Relevance: 18.23541
  • www.novocure.com
  • 3
  • 3
  • 20
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields... Novocure is dedicated to supporting independent organizations with shared goals related to advancing medical care..
Relevance: 18.233442
  • www.dilloncorvino.com
  • 1
I'm a tumor immunologist studying NK cells who is passionate about open access research, genetic barcoding, genetic engineering, and mathematical modeling... I was born and raised in Australia and graduated with my Ph.D in 2019 with a thesis in..
Relevance: 18.204952
  • fg-onko.ru
  • 2
  • 1
Unique molecular identifiers (UMI) are used to ensure the high sensitivity of the method... For selection of approved targeted therapy and involvement in the clinical trials... The confirmation test in the patient's blood sample is required if a..
Relevance: 18.155096
  • www.saltlightpharma.com.au
SALT AND LIGHT PHARMACEUTICALS (SLP) was created to develop new photosensitisers for PDT to make cancer therapy safer and more humane... Conventional cancer therapies kill as they heal. Often the chemotherapy is effective in reducing or eliminating..
Relevance: 17.975489
  • verthermiafoundation.org
  • 3
  • 1
  • 1
The Verthermia Foundation's mission is to extend life for people with terminal cancers who are on The Verthermia Foundation's (TVF) mission is to extend life for people with terminal cancers who are on hospice or are hospice eligible. For those faced..
Relevance: 17.915567
  • warfellab.com
  • 4
  • 1
Toth RK, Warfel NA. Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer. Mol Cancer Ther. (2021) 2020 Dec 10. Review. PubMed PMID: 33303645... Hypoxia (low oxygen) is arguably the most well characterized aspect of tumor biology that..
Relevance: 17.8315
  • www.telexos.de
  • 1
  • 1
We want to be the first company to bring CTC-analysis into the clinical routine to save lives and costs... CTCs reflects the tumor diversity on all levels (protein, DNA, RNA and cellular). Therefore, we believe that CTC will finally be the mostly..
Relevance: 17.78707
  • treovir.com
  • 2
  • 1
  • 5
Treovir was founded in 2019 to develop and commercialize G207 for recurrent glioblastoma in children... Treovir's G207 Therapy demonstrated improved survival in a Phase 1 study without any serious side effects. Treovir strives to change the course..
Relevance: 17.733276
  • devacell.com
  • 1
  • 7
DevaCell's ONCoat™ synthetic vector-based platform technology is enabling transformative, new therapeutic opportunities across three key segments: Oncolytic virus therapy, vaccines and gene therapy/gene editing application. The company's lead..
Relevance: 17.732338
  • hugosnippert.nl
  • 1
  • 9
Hugo Snippert - Functional heterogeneity in cancers... The vast majority of tumors is genetically heterogeneous, meaning that cancers are composed of many different genetic subclones. In recent years, continuous innovation in sequencing techniques..
Relevance: 17.693419
  • www.ionetix.com
  • 4
  • 3
  • 8
IONETIX is a cyclotron and technology company providing full-service radioisotope production and end-to-end radiopharmaceutical manufacturing solutions... More recently, IONETIX is leveraging its growing network of radiopharmaceutical manufacturing..
Relevance: 17.613384
  • www.geno-truthdx.com
  • 1
  • 2
One of the most fundamental changes found in cancer cells is the presence of mutations in oncogenes. The defective proteins produced by these altered genes are ideal targets for a precise cancer therapy. Compared with the traditional chemotherapy..
Relevance: 17.532406
  • tigerstudy.net
Lymph node status is an important prognostic parameter in esophageal carcinoma and an independent predictor of survival. Distribution of metastatic lymph nodes may vary with tumor location, tumor histology, tumor invasion depth and neoadjuvant..
Relevance: 17.518726
  • www.abta.org
  • 2
  • 3
  • 21
The American Brain Tumor Association is the nation's oldest nonprofit organization dedicated to brain tumor education, support and research. In 1973, the ABTA was founded by two mothers determined to find answers that, at the time, were not yet..
Relevance: 17.467585
  • www.djkrause.com
  • 1
  • 1
Managing all creative aspects of the ongoing ES-SCLC indication and 2024 launch of LS-SCLC... Leading the pan tumor team in all marketing aspects across 5 current IMFINZI indications and 5 launches through 2025... OPTUNE • TTFields device therapy..
Relevance: 17.363853
  • www.idrx.com
  • 4
  • 2
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective..
Relevance: 17.213617
  • www.sonalasense.com
  • 1
  • 1
  • 24
SonALAsense is led by an experienced leadership team and Scientific Advisory Board of Key Opinion Leaders and is the first company to advance SDT into clinical trials... SonALAsense is the first company to advance Sonodynamic Therapy into clinical..
Relevance: 17.209602
  • www.leukemia-resistance.de
A major pathomechanism and obstacle for the treatment of malignant disease is resistance of tumor cells against apoptosis and chemotherapy. We hypothesize that a) cell-intrinsic as well as cell-extrinsic mechanisms mediated by the microenvironment..
Relevance: 17.169624
  • www.leukemia-net.de
A major pathomechanism and obstacle for the treatment of malignant disease is resistance of tumor cells against apoptosis and chemotherapy. We hypothesize that a) cell-intrinsic as well as cell-extrinsic mechanisms mediated by the microenvironment..
Relevance: 17.164156
  • www.agpharma.com
  • 2
  • 1
  • 7
At A&G Pharmaceutical, we're ushering in a more personalized approach to the treatment of cancer and other serious diseases by harnessing the power of antibodies to selectively recognize and latch on to the specific cell-surface biomarkers that..
Relevance: 17.122845
  • www.simnovabio.com
  • 1
  • 3
Simnova is a clinical stage biotech company focusing on the development of cell therapy for cancer patients... Simnova Biotechnology was founded in 2019, which as a subsidiary of Simcere Pharmaceuticals, then spun off into an independent operating..
Relevance: 16.974895
  • complimentcorp.com
  • 1
  • 1
Compliment Corporation is a start-up biotechnology company with a new approach to checkpoint inhibition in oncology, a multi-billion-dollar market opportunity. Our proprietary technology platform is based on a novel engineered protein that increase..
Relevance: 16.96003
  • www.xintela.se
  • 5
  • 2
  • 8
Xintela is a biopharma company that develops stem cell-based treatments focusing on osteoarthritis and difficult-to-heal leg ulcers and, through its wholly owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancer, such as..
Relevance: 16.933624
  • dynamicure.com
  • 1
  • 3
Driven by science and passionate about advancing patient care, DynamiCure is translating potentially revolutionizing new insights on immuno-normalization into a pipeline of innovative antibody candidates with first-in-class and best-in-class..
Relevance: 16.91981
  • www.immunorec.gr
  • 1
  • 3
  • 3
ImmunoRec is a spin-off company of the University of Crete aiming to enter phase-I clinical trial on cancer vaccine personalized therapy (patent ΟΒΙ 20190100297). The novel technology is stated by the National Medicinal Organization as Cancer..
Relevance: 16.883732
  • www.radiomics.net.cn
  • 1
  • 2
Radiomics also provides a complementary method of gene analysis. The hypothesis behind this is that gene expression or mutation is reflected in the tumor phenotype (Gatenby, Grove et al. 2013). In the traditional gene analysis process, tumor tissue..
Relevance: 16.86585
  • www.raydiax.com
  • 7
  • 2
  • 4
RAYDIAX mission is to increase the quality of everyday minimally invasive interventions providing the world's first therapy-assist CT system. Our uncompromised imaging solutions enable safe, intuitive, and efficient procedures for patients and..
Relevance: 16.857622